-
Je něco špatně v tomto záznamu ?
Interactions of amyloid β peptide 1-40 and cerebrosterol
Z. Krištofiková, Z. Kříž, D. Rípová, J. Koča,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2009-08-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- amyloidní beta-protein metabolismus MeSH
- hipokampus metabolismus MeSH
- hydroxycholesteroly metabolismus MeSH
- krysa rodu rattus MeSH
- peptidové fragmenty metabolismus MeSH
- potkani Wistar MeSH
- vazba proteinů MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Amyloid β peptides appear to play a role in physiological processes; however, they are also involved in the pathogenesis of Alzheimer disease. Their actions under normal conditions are probably mediated by soluble monomeric L-isoforms at low concentrations, perhaps via highly specific interactions. On the contrary, toxic effects of aggregated natural L-isoforms/synthetic D-isoforms on membranes are very similar, but synthetic reverse/random L: -isoforms without pronounced aggregation properties are not toxic. Our previous work reported interactions of non-aggregated/aggregated L-isoforms of amyloid β peptides 1-40/1-42 with racemic 24-hydroxycholesterol. In this study, stereospecificity in the interactions of natural 24(S)hydroxycholesterol (cerebrosterol) or synthetic 24(R)hydroxycholesterol with soluble fragment 1-40 was evaluated by means of an in vitro test based on increased vulnerability of the hemicholinium-3 sensitive high-affinity choline uptake system in rat hippocampal cholesterol-depleted synaptosomes to the actions of amyloid β; computational simulations were also performed. Our results suggest that: (1) 24(S)hydroxycholesterol interacts with L-peptide 1-40 but not with the reverse L-peptide 40-1, (2) 24(R)hydroxycholesterol does not interact with L-peptide 1-40 or reverse 40-1, and (3) both enantiomers can probably interact with D-peptide 1-40. Therefore, the binding of 24(S)hydroxycholesterol is not fully stereospecific and the interaction could not reflect a physiological mechanism. Data from the computational simulation indicate that the hydrophobic core of the amyloid β molecule interacts with the hydrophobic part of 24(S)hydroxycholesterol, but no hydrogen bonds with high stability were found. Using this procedure, globular amyloid β could retain 24(S)hydroxycholesterol and thus contribute to its pathological accumulation in the brains of patients with Alzheimer disease.
Alzheimer Disease Centre Prague Psychiatric Centre Ústavní 91 181 03 Prague 8 Bohnice Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024276
- 003
- CZ-PrNML
- 005
- 20121210095812.0
- 007
- ta
- 008
- 120815s2012 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11064-011-0650-8 $2 doi
- 035 __
- $a (PubMed)22089933
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krištofiková, Zdena $u Alzheimer Disease Centre, Prague Psychiatric Centre, Ústavní 91, 181 03, Prague 8, Bohnice, Czech Republic. kristofikova@pcp.lf3.cuni.cz
- 245 10
- $a Interactions of amyloid β peptide 1-40 and cerebrosterol / $c Z. Krištofiková, Z. Kříž, D. Rípová, J. Koča,
- 520 9_
- $a Amyloid β peptides appear to play a role in physiological processes; however, they are also involved in the pathogenesis of Alzheimer disease. Their actions under normal conditions are probably mediated by soluble monomeric L-isoforms at low concentrations, perhaps via highly specific interactions. On the contrary, toxic effects of aggregated natural L-isoforms/synthetic D-isoforms on membranes are very similar, but synthetic reverse/random L: -isoforms without pronounced aggregation properties are not toxic. Our previous work reported interactions of non-aggregated/aggregated L-isoforms of amyloid β peptides 1-40/1-42 with racemic 24-hydroxycholesterol. In this study, stereospecificity in the interactions of natural 24(S)hydroxycholesterol (cerebrosterol) or synthetic 24(R)hydroxycholesterol with soluble fragment 1-40 was evaluated by means of an in vitro test based on increased vulnerability of the hemicholinium-3 sensitive high-affinity choline uptake system in rat hippocampal cholesterol-depleted synaptosomes to the actions of amyloid β; computational simulations were also performed. Our results suggest that: (1) 24(S)hydroxycholesterol interacts with L-peptide 1-40 but not with the reverse L-peptide 40-1, (2) 24(R)hydroxycholesterol does not interact with L-peptide 1-40 or reverse 40-1, and (3) both enantiomers can probably interact with D-peptide 1-40. Therefore, the binding of 24(S)hydroxycholesterol is not fully stereospecific and the interaction could not reflect a physiological mechanism. Data from the computational simulation indicate that the hydrophobic core of the amyloid β molecule interacts with the hydrophobic part of 24(S)hydroxycholesterol, but no hydrogen bonds with high stability were found. Using this procedure, globular amyloid β could retain 24(S)hydroxycholesterol and thus contribute to its pathological accumulation in the brains of patients with Alzheimer disease.
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a hipokampus $x metabolismus $7 D006624
- 650 _2
- $a hydroxycholesteroly $x metabolismus $7 D006888
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a peptidové fragmenty $x metabolismus $7 D010446
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kříž, Zdeněk
- 700 1_
- $a Rípová, Daniela
- 700 1_
- $a Koča, Jaroslav
- 773 0_
- $w MED00003484 $t Neurochemical research $x 1573-6903 $g Roč. 37, č. 3 (2012), s. 604-13
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22089933 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20121210095848 $b ABA008
- 999 __
- $a ok $b bmc $g 946424 $s 781604
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 37 $c 3 $d 604-13 $i 1573-6903 $m Neurochemical research $n Neurochem Res $x MED00003484
- LZP __
- $a Pubmed-20120815/12/02